Abstract:Abstract Background In Crohn’s Disease (CD), 10% of patients present with fibrostenosis with a further 10% progressing from inflammatory to a fibrostenotic disease behaviour over 7 years. 40% of fibrostenotic CD patients need surgery at 5 years compared to ~10% with inflammatory disease. Present non-invasive fibrosis biomarkers lack the required accuracy needed to be used routinely for clinical decision making. T1, T2, diffusion weighted imaging, motility and bowel volumes have shown promise in the non-invasive measure of fibrosis. Methods The primary objective of this study is to undertake biological validation of MRI measures as independent imaging biomarkers of histological fibrosis with the primary outcome being the correlation between MRI measures and histological fibrosis measures. GI-Seg (Motilent, London, UK) is an image analysis tool used to segment the gastrointestinal tract on T2W MRI scans. Patients with CD histological diagnosis and in need of surgical resection for stenosis attended a one-hour 3T MRI scanning session within 12 weeks prior to their intestinal resection surgery. Histological samples were scored by a specialized gastrointestinal pathologist for inflammation, fibrosis, and muscular hypertrophy. An expert radiologist with the help of the histopathologist located the strictures on DWI, quantitative T2&T2 scans, and T2 weighted clinical MRI scans. GI-Seg was used to generate a 3D model of the stricture on T2W scans measuring bowel wall volume and average signal intensity of each stricture. Pearson correlation coefficient was used to quantify the correlation between the variables. Results A total of 10 CD patients, encompassing 20 strictures, were included in the study. The analysis revealed that the average T2 signal has a significant correlation with global fibrosis scores (r(20) = .563, p = .010) (Figure) and total inflammation scores (r(20) = .451, p = .046). Additionally, stricture volume showed a fair correlation with chronic inflammation component scores (r(20) = .453, p = .045). Notably, quantitative T1 values correlated with total inflammation scores (r(17) = .493, p = .045). Conclusion The study reveals fair correlations between the T2 signal average and both global fibrosis and global inflammation scores, as well as between stricture volume and chronic inflammation in CD strictures. While these findings indicate that the GI-seg tool's measurements of bowel wall volume and signal intensity have potential utility as imaging biomarkers for fibrosis and inflammation, the results also underscore the necessity for additional markers that are specifically correlated with fibrosis. Such markers are essential to distinctly identify fibrotic changes, independent of inflammatory processes.

DWI ratios: New indexes for Crohn's disease activity at magnetic resonance enterography?

Utility of the diffusion-weighted imaging for activity evaluation in Crohn’s disease patients underwent magnetic resonance enterography

Diffusion-Weighted Mri Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn'S Disease: Results from an Observational Study

Assessment of Activity of Crohn Disease by Diffusion-Weighted Magnetic Resonance Imaging.

P246 Risk Factors Associated with Low Ovarian Reserve in Young Women of Reproductive Age with Crohn's Disease

Crohn’s disease of the small bowel: evaluation of ileal inflammation by diffusion-weighted MR imaging and correlation with the Harvey-Bradshaw index

Detection of Crohn's disease with diffusion images versus contrast-enhanced images in pediatric using MR enterography with histopathological correlation

Clinical role of MR diffusion-weighted imaging in the evaluation of intestinal Crohn's disease and its inflammation activity

The sensitivity and specificity of CT enterography comprehensive score in evaluating the activity of Crohn's disease

Application Advances on DWI and MRE in Inflammatory Bowel Disease

Evaluating the inflammatory activity in Crohn’s disease using magnetic resonance diffusion kurtosis imaging

Influence of diffusion weighted imaging and contrast enhanced T1 sequences on the diagnostic accuracy of magnetic resonance enterography for Crohn's disease

Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease

Magnetic Resonance Imaging and Crohn’s Disease Endoscopic Index of Severity: Correlations and Concordance

P013 Magnetic Resonance Imaging-Based Average T2 Signal as A Non-Invasive Measure of Fibrosis In Enteric Crohn’s Disease

MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report

Multiparametric MRI for Staging of Bowel Inflammatory Activity in Crohn's Disease with MUSE-IVIM and DCE-MRI: A Preliminary Study

Reporting of Magnetic Resonance Enterography in Inflammatory Bowel Disease: Results of an Italian Survey

Semi-automatic Crohn’s Disease Severity Estimation on MR Imaging

IDDF2019-ABS-0186 Correlation Between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease

Imaging of Ulcerative Colitis: The Role of Diffusion-Weighted Magnetic Resonance Imaging